473 filings
8-K
MTNB
Matinas Biopharma Holdings Inc
5 Apr 24
Matinas BioPharma Announces Registered Direct Offering of $10 Million
7:00am
424B5
MTNB
Matinas Biopharma Holdings Inc
4 Apr 24
Prospectus supplement for primary offering
4:15pm
8-K
MTNB
Matinas Biopharma Holdings Inc
28 Mar 24
Regulation FD Disclosure
9:00am
8-K
MTNB
Matinas Biopharma Holdings Inc
27 Mar 24
Matinas BioPharma Reports 2023 Financial Results and Provides a Business Update
4:22pm
10-K
2023 FY
MTNB
Matinas Biopharma Holdings Inc
Annual report
27 Mar 24
4:02pm
8-K
MTNB
Matinas Biopharma Holdings Inc
25 Mar 24
Matinas BioPharma Announces Positive in vivo Safety Data with its Oral LNC-Docetaxel Formulation
8:05am
8-K
MTNB
Matinas Biopharma Holdings Inc
22 Mar 24
Regulation FD Disclosure
9:20am
8-K
MTNB
Matinas Biopharma Holdings Inc
22 Mar 24
Other Events
6:35am
8-K
MTNB
Matinas Biopharma Holdings Inc
26 Feb 24
Regulation FD Disclosure
8:05am
8-K
MTNB
Matinas Biopharma Holdings Inc
20 Feb 24
Regulation FD Disclosure
7:35am
8-K
MTNB
Matinas Biopharma Holdings Inc
9 Jan 24
Regulation FD Disclosure
7:30am
8-K
MTNB
Matinas Biopharma Holdings Inc
27 Dec 23
In an acute psoriasis model, data show reductions in tissue IL-17A mRNA and improvement in clinical disease markers including skin lesions
7:40am
8-K
MTNB
Matinas Biopharma Holdings Inc
21 Dec 23
Matinas BioPharma Provides Update to MAT2203 Regulatory and Development Pathway Following Feedback from FDA
7:40am
4
Matkovits Theresa
15 Dec 23
Matinas BioPharma / Theresa Matkovits ownership change
9:46pm
4
MTNB
Matinas Biopharma Holdings Inc
15 Dec 23
Matinas BioPharma / Thomas Hoover ownership change
9:46pm
4
Kucinski Keith A
15 Dec 23
Matinas BioPharma / Keith A Kucinski ownership change
9:46pm
4
Liu Hui
15 Dec 23
Matinas BioPharma / Hui Liu ownership change
9:46pm
4
Jabbour Jerome D
15 Dec 23
Matinas BioPharma / Jerome D Jabbour ownership change
9:46pm
4
Ferguson James J. III
15 Dec 23
Matinas BioPharma / James J. Ferguson III ownership change
9:46pm
8-K
MTNB
Matinas Biopharma Holdings Inc
20 Nov 23
Regulation FD Disclosure
7:30am